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Abstract 
Introduction:  The extraventricular neurocytoma of the sellar region (EVNSR) is a rare disease, it is difficult to make 
exact diagnosis of and operate on patients. Retrospectively analysed the clinical manifestations, image features, 
therapy methods and outcomes among patients with EVNSR, to investigate the epidemiological characteristics, 
image features, diagnosis, treatment and prognosis.
Case description: A 25‑year‑old man man with 7‑month worsening vision of left eye, was confirmed EVNSR after 
subtotally resection from the neurosurgical department of Deji hospital.
Discussion and evaluation: Nine cases of EVNSR were reported from this article and elsewhere. Ages of these 
patients were ranging from 25 to 66 (with an average of 45.67). The male–female ratio was 1–2. All EVNSR patients 
had visual damage. Images showed the tumors were in the sellar and suprasellar regions. Preoperatively, all patients 
were misdiagnosed as other diseases: such as pituitary tumor, craniopharyngioma, and meningioma. For tumor 
removal treatment, five patients received transpterional approach, one received subfrontal approach and three 
received transnostril–transsphenoidal approach. EVNSR was confirmed by pathological tests. The tumor was com‑
pletely removed in one patient. During the 12–24 month postoperative follow up period, the recurrence or metastasis 
of the tumor was found in two patients.
Conclusions: EVNSR is a rare disease. It occurs mostly in middle‑aged women. EVNSR is likely to be misdiagnosed 
as pituitary adenoma preoperatively. The histological examination would help confirm the diagnosis. Using transpte‑
rional approach to remove tumor will help the prognosis, especially among patients with normal pituitary function. 
Both postoperative radiotherapy and long‑term follow‑up are recommended.
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Introduction
The extraventricular neurocytoma of the sellar region 
(EVNSR) is a rare disease, with only eigh cases reported 
in literature up to now. It is difficult to make exact diag-
nosis of and operate on patients with EVNSR. We report 
one EVNSR patient receiving radiotherapy on the 5th 
months after subtotally resection from the neurosurgi-
cal department of Deji hospital, Shanghai. We also review 
the pertinent literatures to investigate the diagnosis, 
treatment and prognosis of EVNSR.
Case presentation
A 25-year-old man had had worsening vision of left 
eye since 7 months ago. There was no history of head-
ache, vomiting, polydipsia, polyuria or sexual dys-
function. The case was obese and well-nourished and 
appeared to be apathic. The visual acuity of right eye 
was 0.8, while the left eye could only count fingers 
within 30 cm. There were signs of bitemporal visual field 
defect, delayed light reflex of the left pupil and slight 
abduct limitation in left eye. Computed tomography 
scan showed a roundish homogenous and mildly high 
density mass in the sellar and suprasellar regions, with 
clear margin, intra-tumor calcification, but no periph-
ery edema (Fig.  1). The magnetic resonance imaging 
showed the roundish intrasellar and suprasellar mass of 
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measured 3.9  cm ×  3.6  cm ×  3.0  cm located slight to 
the left, which invaded the anterior skull base, cavern-
ous sinus and upper clivus. There were signals of slight 
hypointense on T1-weighted images (Fig.  2a), slight 
hyperintense on T2-weighted images (Fig.  2b), moder-
ate nonhomogeneous enhancement (Fig. 2c, d) and the 
dural tail sign (Fig. 2d), All signals were with clear mar-
gin and without periphery edema (Fig. 2a–d). Endocrine 
tests of the hypothalamic–pituitary axis were normal.
A left transpterional craniotomy exposed the tumor, 
which was mainly located in suprasellar region and was 
partially extended into the intrasellar, anterior skull base, 
cavernous sinus and upper clivus (Fig. 3a–c). The tumor 
had soft texture, clear boundary, crimson and hyper-
vascularity. The bilateral optic nerves were compressed 
severely (Fig. 3a, b). The tumor was then separated along 
its pseudocapsular margin, and was resected in the inter-
space I, II, III, respectively (Fig. 3d–f). The tumor in the 
intrasellar and cavernous sinus was partially removed. 
The bilateral optic nerves were decompressed well after 
tumor resection (Fig. 3d, e). The pituitary stalk, bilateral 
internal carotid arteries, oculomotor nerves and poste-
rior communicating artery were also protected.
The resected specimen was grey and soft. Histopatho-
logic examination (HE) staining showed that tumor cells 
were oval and well-differentiated with schistic distribu-
tion. Cytoplasm was sparse with mild acidophilia. Nuclei 
were oval, without obvious heteromorphosis and mitotic 
figures. Neuropil structure was observed in some region 
of the tumor tissues, without necrosis (Fig. 4a). Immuno-
histochemical  staining showed that the neuronal mark-
ers such as Synaptophysin, NeuN and Alpha-internexin 
were highly positive (Fig.  4b–c). Other markers includ-
ing the glial marker (GFAP), epithelial marker (CK) and 
Fig. 1 The preoperative cranial CT scan showing a high‑density mass 
in the suprasellar cistern with spot intratumoral calcification
Fig. 2 The pre‑ and post‑operative MRI. a–d Preoperative MRI showing a intrasellar and suprasellar tumor extending to anterior skull base and 
superior clivus. e, f The postoperative enhanced MRI showing subtotal tumor removal, with a little tumor remained in the intrasellar region
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anterior pituitary hormones markers (such as GH, PRL, 
TSH, FSH, LH and ACTH) were negative. The p53 albu-
men had no mutation. The Ki67 index was around 3  % 
(Fig.  4d). Pathologic diagnosis was the extraventricular 
neurocytoma (WHO II).
The patient’s visual acuity improved on the second 
postoperative day. The patient developed a mild diabetes 
insipidus but recovered after hypophysin therapy. Cranial 
MRI showed subtotal tumor removal, with a little tumor 
remained in intrasellar region (Fig.  2e, f ). One week 
later, the patient developed an epileptic seizure and was 
treated by oxcarbazepine. The patient was discharged 
from hospital after 14 days after the surgery.
Three-month postoperative follow-up showed patient’s 
left visual acuity increased to 0.12 with improvement on 
vision defect. The anterior pituitary hormone tests were 
normal. Cranial MRI results were similar as the one taken 
on the second postoperative day.
Discussion
Central neurocytoma (CN) is a neuronal and mixed neu-
ronal-glial tumor. It is classified as a WHO II grade tumor 
(Louis et  al. 2007). Central neurocytoma is often called 
the intraventricular neurocytoma as it originates from 
septum  pellucidum or lateral ventricles, and it grows 
mostly in the ventricle system. Since the first record by 
Hassoun in 1982, there has been about 500 cases with 
CN reported, accounting for 0.10–0.50 % of patients with 
intracranial tumors. The age of onset is ranging from 40 
to 60 years old in 70 % of patients, without gender differ-
ence (Choudhari et al. 2009).
Central neurocytoma of extraventricular regions is 
called extraventricular neurocytoma (EVN). Nearly 100 
cases of EVN has been reported, accounting for 0.02–
0.10 % of patients with intracranial tumors. EVN is com-
monly observed among Asians, especially Japanese. The 
patients’ ages range from 5 to 76 years old with an aver-
age of 34 years old. There is no gender difference (Choi 
et al. 2011; Choudhari et al. 2009). EVN is mostly located 
at frontal lobe, secondly at parietal lobe. It has also been 
found at cerebellum, thalamus, brain stem, sellar and spi-
nal cord, as well as regions apart from nervous system 
such as the retroperitoneal, abdomen, pelvis (Xiao 2013).
Central neurocytoma originated from the sellar region 
is called extraventricular neurocytoma of the sellar 
region (EVNSR). EVNSR is a rare disease with only eight 
cases reported till now. The patients’ age range is from 
25 to 66 years old with an average of 45.67 years old. The 
male–female is 1–2 (Table 1). The major clinical manifes-
tations of EVNSR are hypopsia and vision field defection. 
Fig. 3 Intraoperative photograph. a–c The tumor being showed at the interspace I (a), interspace II (b), interspace III (c). d–f The tumors being 
resected in the interspace I (d), II (e), III (f)
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Headache, dizziness, and symptoms of the hypertensive 
intracranial syndrome would also occur. When the tumor 
erodes pituitary gland or cavernous sinus, endocrinologi-
cal disorder or impairment of cranial never III or/and VI 
would occur (Chen et  al. 2011). The tumor is round or 
roundish, sharply defined towards surroundings. The 
tumor shows slightly high-density on plain CT scan, and 
has nonhomogeneous enhancing appearance on con-
trast-enhanced CT scan. Schistic or granular calcifica-
tion is found over half of the cases, however hemorrhage 
rarely occurs (Delmaire et  al. 2011). The tumor often 
shows equal or little long T1 signal and equal or long T2 
signal. Cyst, calcification and vascular flow voids could 
be observed when the signal is nonhomogeneous. On the 
postgadolinium T1-weighted images, the solid part of the 
tumor shows moderate enhancement (Dominguez-Paez 
et al. 2011). Since the lack of specificities in clinical mani-
festations and imaging appearance, EVNSR is often mis-
diagnosed as other diseases (Table  1). Some literatures 
recommend MRS examination as an alternative way of 
differentiation (Kim et al. 2000).
EVNSR is recommended to be removed as much as 
possible with minimally invasive technique. Clinically, 
either surgical approach or endoscopic endonasal–trans-
sphenoidal approach will be adopted based on tumor 
extending direction. The key of treatment is to decom-
press the optic pathway and to protect the neuro-vascu-
lar structure of surgical region. The endoscopic approach 
may be more effective to protect the optic nerves by caus-
ing lesser lesion compared to the craniotomy approach. 
However, the endoscopic approach may aggravate pitui-
tary malfunction if the tumor evaded to the suprasellar 
region and remained pituitary tissue. Reconstruction of 
anterior skull base could be considered via the extended 
endoscopic approach. But it is not recommended in 
patients with uncertain diagnosis or in patients with 
tumor barely eroding the sphenoid sinus.
In our reported case, the preoperative hormone test 
and image results showed the pituitary gland might 
remain functional. Instead of the endoscopic endonasal 
transsphenoidal approach, we decided to use transpteri-
onal approach, which we also had more experiences with. 
Fig. 4 The HE staining and immunohistochemical staining. a (HE × 200) Oval well‑differentiated tumor cell presenting schistic distribution, with 
neuropil structure observed in some region. b–d (Leica BOND‑MAX automatic immunohistochemical staining machine × 200) The markers of 
NeuN (b) and Alpha‑internexin (c) expressing strongly positive, and the Ki67 index being 3 % (d)
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Since the tumor slightly predominated at the left side 
with decreased visual acuity of left eye, we adopted the 
left transpterional approach to decompress the left optic 
nerve and to protect the well-functional right one. Micro-
scopically, we successfully resected the tumor in anterior 
skullbase, the interspace I, II, III, and partial ones in the 
intrasellar region and the cavernous sinus (Figs. 2, 3). The 
patient received the radiotherapy (2GY*24, total 48GY) 
on the fifth postoperative month. The MRI showed obvi-
ous tumor reduction on the eighth postoperative month.
The necessity of the postoperative radiotherapy is still 
controversial. Most scholars believed radiotherapy is 
effective, especially among cases with partial removal or 
tumor recurrence. While past cases indicated the total 
tumor resection to be a more important prognostic fac-
tor than postoperative radiotherapy (Table  1), a small 
number of scholars believed that the overall prognosis 
is affected by the postoperative radiotherapy (Kim et al. 
2013). More patients and longer follow up are needed to 
make more relevant evaluation for radiotherapy.
Some authors believed EVN had ganglionic and 
neuroglial differentiation, with higher radio of patho-
logically atypical features and more postoperative recur-
rence (Chou et  al. 2010). Kane et  al. (2012) reported a 
44 % 5-year recurrence rate of total eighty-five patients 
with EVNs and a 14  % 5-year mortality rate. Akshay S 
concluded in his retrospective analysis that the tumor 
resection extent was the main prognostic factor, fol-
lowed by atypical histological features and the patient’s 
age. The EVNs were more likely to recur in patients 
at the age of below 18  years old or above 50  years old 
(Patil et  al. 2014). In nearly 100 patients with EVNs 
reported by Kawaji et  al. (2014), five had metastatic 
focus with one located at cerebellum, three in cranio-
spinal region and one in distant dural. Longer follow-
up is needed, especially among patients with residual 
tumors after operation or atypical tumors (Ki67 > 2 %) 
and patients at age below 18  years old/above 50  years 
old. When patient has neurological symptoms and signs 
hardly explained by tumor recurrence, tumor metasta-
sis should be suspected. In the meantime, the imaging 
reexamination should be done not only in the surgi-
cal regions but also in the regions in which metastasis 
suspected.
Abbreviation
EVNSR: extraventricular neurocytoma of sellar region.
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